Henri Leinonen

11PUBLICATIONS
64CO-AUTHORS
Molecular targetsPharmaceutical delivery technologiesNeurology and neuromuscular diseasesRehabilitation engineeringFine arts
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 11, 2025
Drug-Free Approach to Regulate Undruggable Proto-Oncogene MYC Using Biomimetic Porous Nanoparticles for Cancer Immunotherapy.

Emilia Happonen, Yijing Dang, Jiajia Wang

|Jul 09, 2025
Cyclic nucleotide signaling as a drug target in retinitis pigmentosa.

Katri Vainionpää, Ahmed B Montaser, Henri Leinonen

|Mar 19, 2025
Computational drug repurposing: approaches, evaluation of in silico resources and case studies.

Ziaurrehman Tanoli, Adrià Fernández-Torras, Umut Onur Özcan

|Jul 15, 2024
A combination treatment based on drug repurposing demonstrates mutation-agnostic efficacy in pre-clinical retinopathy models.

Henri Leinonen, Jianye Zhang, Laurence M Occelli

|Feb 24, 2024
Metabolic characteristics of transmembrane prolyl 4-hydroxylase (P4H-TM) deficient mice.

Tuulia Ala-Nisula, Riikka Halmetoja, Henri Leinonen

|May 01, 2023
Stress resilience-enhancing drugs preserve tissue structure and function in degenerating retina via phosphodiesterase inhibition.

Jennings C Luu, Aicha Saadane, Henri Leinonen

Pageof 2

Frequent Collaborators

6 joint publications

Krzysztof Palczewski

5 joint publications

Philip D Kiser

3 joint publications

Andrzej T Foik

2 joint publications

Dominik Lewandowski